The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCOLADE INC | COM | 00437E102 | 2,184 | 124,393 | SH | SOLE | 124,393 | 0 | 0 | ||
| AGILON HEALTH INC | COM | 00857U107 | 3,549 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| ALBIREO PHARMA INC | COM | 01345P106 | 14,318 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 6,224 | 1,400,239 | SH | SOLE | 1,400,239 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 3,707 | 22,704 | SH | SOLE | 22,704 | 0 | 0 | ||
| CHARLES RIV LABS INTL INC | COM | 159864107 | 8,945 | 31,500 | SH | SOLE | 31,500 | 0 | 0 | ||
| COGNITION THERAPEUTICS INC | COM | 19243B102 | 660 | 240,080 | SH | SOLE | 240,080 | 0 | 0 | ||
| CONVEY HEALTH SOLUTIONS HLDG | COM | 21258C108 | 4,893 | 748,134 | SH | SOLE | 748,134 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 2,134 | 34,000 | SH | SOLE | 34,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | COM | 22978P106 | 7,370 | 1,510,282 | SH | SOLE | 1,510,282 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 292 | 93,923 | SH | SOLE | 93,923 | 0 | 0 | ||
| ENCOMPASS HEALTH CORP | COM | 29261A100 | 2,837 | 39,900 | SH | SOLE | 39,900 | 0 | 0 | ||
| GALAPAGOS NV | CALL | 36315X901 | 12,094 | 195,000 | SH | Call | SOLE | 195,000 | 0 | 0 | |
| GALAPAGOS NV | SPON ADR | 36315X101 | 23,195 | 374,000 | SH | SOLE | 374,000 | 0 | 0 | ||
| GLOBUS MED INC | CL A | 379577208 | 1,328 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
| INMODE LTD | SHS | M5425M103 | 1,846 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 333 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 8,686 | 589,270 | SH | SOLE | 589,270 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 4,986 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MEIRAGTX HLDGS PLC | COM | G59665102 | 5,273 | 380,700 | SH | SOLE | 380,700 | 0 | 0 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,628 | 73,930 | SH | SOLE | 73,930 | 0 | 0 | ||
| NEOGENOMICS INC | COM NEW | 64049M209 | 772 | 63,524 | SH | SOLE | 63,524 | 0 | 0 | ||
| ORGANON & CO | PUT | 68622V956 | 699 | 20,000 | SH | Put | SOLE | 20,000 | 0 | 0 | |
| OSCAR HEALTH INC | CL A | 687793109 | 2,368 | 237,500 | SH | SOLE | 237,500 | 0 | 0 | ||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 542 | 599,288 | SH | SOLE | 599,288 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 20,718 | 566,538 | SH | SOLE | 566,538 | 0 | 0 | ||
| QUIDEL CORP | COM | 74838J101 | 2,887 | 25,675 | SH | SOLE | 25,675 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 3,224 | 203,268 | SH | SOLE | 203,268 | 0 | 0 | ||
| SELECT MED HLDGS CORP | COM | 81619Q105 | 2,178 | 90,788 | SH | SOLE | 90,788 | 0 | 0 | ||
| SHATTUCK LABS INC | COM | 82024L103 | 3,403 | 798,718 | SH | SOLE | 798,718 | 0 | 0 | ||
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 1,142 | 325,365 | SH | SOLE | 325,365 | 0 | 0 | ||
| SIO GENE THERAPIES INC | COMMON | 829399104 | 449 | 670,300 | SH | SOLE | 670,300 | 0 | 0 | ||